Genetic Testing and Molecular Biomarkers

Editor-in-Chief: Garth D. Ehrlich, PhD, FAAAS

ISSN: 1945-0265 | Online ISSN: 1945-0257 | Published Monthly | Current Volume: 27

Impact Factor: 1.736* *2021 Journal Citation Reports™ (Clarivate, 2022)

CiteScore™: 2.7

Providing authoritative, peer-reviewed research on the development of new genetic testing technologies and the ethical, legal, social, and economic issues associated with genetic testing.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts View Submission Instructions Share with a Colleague

News Releases

Monday, April 22, 2019

Promise of Liquid Biopsy in Cancer Biomarker Detection and Prenatal Screening

Tuesday, December 5, 2017

Researchers Examine Role of Gene Variation Linked to Major Depressive Disorder

Wednesday, September 27, 2017

The Benefits and Dangers When Genetic Testing Companies Partner with Orphan Drug Developers

Friday, July 21, 2017

A Genetic Variation May Increase Tuberculosis Susceptibility

Wednesday, April 5, 2017

Are Biobank Donor Families Worried About a Confidentiality Breach?

Monday, April 3, 2017

Ethical Issues Complicate Clinical Interpretation and Reporting of Human Genome Sequence Results

Thursday, November 3, 2016

New Metabolomic Screening Method Detects Multiple Inborn Errors of Metabolism in Urine

Tuesday, August 2, 2016

Study Shows Cell-Free DNA Sequencing Is More Accurate for Diagnosing Myelodysplastic Syndrome

Tuesday, April 26, 2016

What’s Missing from Current Methods for Genetic Screening of Sperm Donors?

Monday, December 15, 2014

New Colorectal Cancer Risk Factor Identified

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.